DGAP-News: VERBIO Vereinigte BioEnergie AG
/ Key word(s): Quarterly / Interim Statement
VERBIO AG: Results for the first quarter of the financial year 2021/2022 in line with expectations
Leipzig, November 11, 2021 - VERBIO AG reports a slight decrease in its results for the first three months of the financial year 2021/2022 compared to the same period in the previous year. Group revenues increased further, with an increase of 34 percent to EUR 350.4 million compared to the previous year (Q1 2020/2021: EUR 261.4 million). Earnings before interest, taxation, depreciation and amortisation (EBITDA) for the first three months of the financial year 2021/2022 amounted to EUR 40.2 million, below the level in the comparative period in the previous year (Q1 2020/2021: EUR 53.3 million). The Group result before interest and taxes (EBIT) totalled EUR 33.1 million (Q1 2020/2021: EUR 45.6 million). The net result for the period amounted to EUR 22.6 million (Q1 2020/2021: EUR 31.7 million). Based on the result for the period, earnings per share are EUR 0.36 (Q1 2020/2021: EUR 0.50). Development of the Biodiesel and Bioethanol segments The margins in Bioethanol were below the levels of the first quarter of the previous year. However, despite the increase in raw material costs, the margins were significantly above those seen at the end of the previous financial year. This was due to the continued record levels in the prices for ethanol seen in the first quarter of 2021/2022 and thereafter. Driven by investments made in property, plant and equipment, total cash outflows in the first three months of 2021/2022 amounted to EUR 20.2 million (Q1 2020/2021: EUR 11.2 million), which also corresponds to the total cash flows from investing activities. Detailed information on business developments in the first three months of the 2021/2022 financial year are provided in the quarterly interim statement for the period ended September 30, 2021. The report can be viewed from 9 a.m. (CET) on VERBIO's website at www.verbio.de. Important notice Information about VERBIO Vereinigte BioEnergie AG (VERBIO) Contact: VERBIO Vereinigte BioEnergie AG Ritterstraße 23 (Oelßner's Hof) 04109 Leipzig Constanze Blechschmidt (IR) Ulrike Kurze (PR) Phone: +49(0)341/308530-281 Fax: +49(0)341/308530-998 Email: ir@verbio.de/pr@verbio.de
11.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | VERBIO Vereinigte BioEnergie AG |
Ritterstraße 23 (Oelßners Hof) | |
04109 Leipzig | |
Germany | |
Phone: | +49 (0)341 308530-0 |
Fax: | +49 (0)341 308530-998 |
E-mail: | ir@verbio.de |
Internet: | www.verbio.de |
ISIN: | DE000A0JL9W6 |
WKN: | A0JL9W |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1247912 |
End of News | DGAP News Service |
|
1247912 11.11.2021
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.